These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9533371)

  • 21. Comparison of two methods of surfactant administration and the effect on dosing-associated hypoxemia.
    Nelson M; Nicks JJ; Becker MA; Vrlenich LA; Bhatt-Mehta V; Schumacher RE
    J Perinatol; 1997; 17(6):450-4. PubMed ID: 9447531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery.
    Pinheiro JM; Santana-Rivas Q; Pezzano C
    J Perinatol; 2016 Mar; 36(3):196-201. PubMed ID: 26633145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial.
    Willson DF; Thomas NJ; Markovitz BP; Bauman LA; DiCarlo JV; Pon S; Jacobs BR; Jefferson LS; Conaway MR; Egan EA;
    JAMA; 2005 Jan; 293(4):470-6. PubMed ID: 15671432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of effects of endotracheal suction and surfactant administration on hemodynamics and oxygenation of premature infants--a near infrared spectroscopy study].
    Roll C; Horsch S; Knief J; Hüsing J; Hanssler L
    Z Geburtshilfe Neonatol; 2001; 205(3):104-9. PubMed ID: 11474988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.
    Gortner L; Bartmann P; Pohlandt F; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Bremer C; Jorch G
    Pediatr Pulmonol; 1992 Sep; 14(1):4-9. PubMed ID: 1437342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hypoxemic respiratory failure.
    Thomas NJ; Guardia CG; Moya FR; Cheifetz IM; Markovitz B; Cruces P; Barton P; Segal R; Simmons P; Randolph AG;
    Pediatr Crit Care Med; 2012 Nov; 13(6):646-53. PubMed ID: 22791092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endotracheal administration of surfactant in very low birth weight infants with respiratory distress syndrome.
    Svenningsen N; Robertson B; Andreason B; Berggren P; Jonson B; Lindroth M
    Crit Care Med; 1987 Oct; 15(10):918-22. PubMed ID: 3652706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing > or = 1250 grams with respiratory distress syndrome. American Exosurf Neonatal Study Group II.
    Berry DD; Pramanik AK; Philips JB; Buchter DS; Kanarek KS; Easa D; Kopelman AE; Edwards K; Long W
    J Pediatr; 1994 Feb; 124(2):294-301. PubMed ID: 8301442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
    Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
    Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
    N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial.
    Egberts J; de Winter JP; Sedin G; de Kleine MJ; Broberger U; van Bel F; Curstedt T; Robertson B
    Pediatrics; 1993 Dec; 92(6):768-74. PubMed ID: 8233735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome. The Collaborative European Multicentre Study Group.
    Bevilacqua G; Halliday H; Parmigiani S; Robertson B
    J Perinat Med; 1993; 21(5):329-40. PubMed ID: 8126628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study].
    Verder H; Agertoft L; Albertsen P; Christensen NC; Curstedt T; Ebbesen F; Greisen G; Hobolth N; Holm V; Jacobsen T
    Ugeskr Laeger; 1992 Jul; 154(31):2136-9. PubMed ID: 1509593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.